Anemia drugs to carry stronger warning

11/8/2007 | Wall Street Journal (free content), The · Yahoo!

The FDA has strengthened warning labels on Amgen's anemia drugs Aranesp and Epogen, as well as Johnson & Johnson's Procrit, to advise of a link to tumor growth and lowered survival rates in cancer patients. The drugmakers say that the FDA's warning is specific to a certain use of the drug and that it is safe for other cancer and kidney patients.

View Full Article in:

Wall Street Journal (free content), The · Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN